Dysregulation of several miRNAs involved in epigenetic activation of the Ras/ERK pathway have been investigated in different cancer types [26], but few studies have addressed miRNAs targeting Ras/ERK signaling molecules in breast cancer. Here, MAPK1 is linked to breast carcinoma.